Managing established coronary heart disease.
Moher
M
M
Schofield
T
T
Weston
S
S
Fullard
E
E
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy / Q000534:rehabilitation / Q000628:therapy*; D005260:Female; D006293:Health Promotion / Q000379:methods*; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011320:Primary Health Care / Q000379:methods*; D018570:Risk Assessment; D016896:Treatment Outcome; D006113:United Kingdom
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000924:Anticholesteremic Agents; D010975:Platelet Aggregation Inhibitors